World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
84
Citations
26032
World Ranking
1370
National Ranking
89

Overview

Robert Zeiser is affiliated with the University of Freiburg in Germany and has contributed extensively to the field of medicine, with a particular focus on hematology and immunology. Their research spans multiple subfields including oncology, genetics, and molecular biology, reflecting a broad scope within medical science.

The scientist has been involved in research topics centered on hematopoietic stem cell transplantation, immune cell function and interaction, and acute myeloid leukemia. Other notable areas of work include chronic myeloid leukemia treatments, CAR-T cell therapy research, acute lymphoblastic leukemia research, and T-cell and B-cell immunology.

Frequent collaborators in Robert Zeiser's work include Geoffroy Andrieux, Melanie Boerries, Justus Duyster, Ralph Wäsch, and Lukas M. Braun. The volume of their joint work suggests ongoing cooperative efforts within their research community.

The following publication venues are where Robert Zeiser has frequently published:

  • Blood
  • Bone Marrow Transplantation
  • Transplantation and Cellular Therapy
  • Frontiers in Immunology
  • Blood Advances

Several recent papers involving Robert Zeiser include the following:

  • Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease, 2020, New England Journal of Medicine
  • Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease, 2021, New England Journal of Medicine

Other influential works listed in their research environment include:

  • Sorafenib Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia With FLT3-Internal Tandem Duplication Mutation (SORMAIN), 2020, Journal of Clinical Oncology
  • Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation, 2020, The Lancet Haematology
  • Immune modulatory effects of oncogenic KRAS in cancer, 2020, Nature Communications

Best Publications

  • Acute Graft-versus-Host Disease — Biologic Process, Prevention, and Therapy

    Robert Zeiser;Bruce R Blazar

  • Origin, fate and dynamics of macrophages at central nervous system interfaces.

    Tobias Goldmann;Peter Wieghofer;Marta Joana Costa Jordão;Fabiola Prutek

  • Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease

    Robert Zeiser;Nikolas von Bubnoff;Jason Butler;Mohamad Mohty

  • Pathophysiology of Chronic Graft-versus-Host Disease and Therapeutic Targets.

    Robert Zeiser;Bruce R Blazar

  • Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey

    R. Zeiser;A. Burchert;C. Lengerke;M.M. Verbeek

  • Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production

    Robert S Zeiser;Vu H Nguyen;Andreas Beilhack;Martin Buess

  • Sorafenib Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia With FLT3–Internal Tandem Duplication Mutation (SORMAIN)

    Andreas Burchert;Gesine Bug;Lea V. Fritz;Jürgen Finke

  • Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation

    Olaf Penack;Monia Marchetti;Tapani Ruutu;Mahmoud Aljurf

  • Graft-versus-host disease is enhanced by extracellular ATP activating P2X7R

    Konrad Wilhelm;Jayanthi Ganesan;Tobias Müller;Christoph Dürr

  • Ferri-liposomes as an MRI-visible drug-delivery system for targeting tumours and their microenvironment

    Georgy Mikhaylov;Ursa Mikac;Anna A. Magaeva;Volya I. Itin

  • Activity of therapeutic JAK 1/2 blockade in graft-versus-host disease.

    Silvia Spoerl;Nimitha R. Mathew;Michael Bscheider;Annette Schmitt-Graeff

  • Differential impact of mammalian target of rapamycin inhibition on CD4 + CD25 + Foxp3 + regulatory T cells compared with conventional CD4 + T cells

    Robert Zeiser;Dennis B. Leveson-Gower;Elizabeth A. Zambricki;Neeraja Kambham

  • Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation

    Cristina Toffalori;Laura Zito;Valentina Gambacorta;Michela Riba

  • CD4+ T Cells Contribute to the Remodeling of the Microenvironment Required for Sustained Tumor Regression upon Oncogene Inactivation

    Kavya Rakhra;Pavan Bachireddy;Tahera Zabuawala;Robert Zeiser

  • Immunodominance and functional alterations of tumor‐associated antigen‐specific CD8+ T‐cell responses in hepatocellular carcinoma

    Tobias Flecken;Nathalie Schmidt;Sandra Hild;Emma Gostick

  • Absence of NKG2D ligands defines leukaemia stem cells and mediates their immune evasion

    Anna M. Paczulla;Kathrin Rothfelder;Simon Raffel;Simon Raffel;Martina Konantz

  • Continuous T Cell Receptor Signals Maintain a Functional Regulatory T Cell Pool

    J. Christoph Vahl;Christoph Drees;Klaus Heger;Sylvia Heink

  • Immune modulatory effects of oncogenic KRAS in cancer

    Shaima’a Hamarsheh;Olaf Groß;Olaf Groß;Tilman Brummer;Tilman Brummer;Robert Zeiser

  • Neutrophil granulocytes recruited upon translocation of intestinal bacteria enhance graft-versus-host disease via tissue damage

    Lukas Schwab;Luise Goroncy;Senthilnathan Palaniyandi;Sanjivan Gautam

  • Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells.

    Nimitha R Mathew;Nimitha R Mathew;Francis Baumgartner;Lukas Braun;David O'Sullivan

  • In vivo dynamics of regulatory T-cell trafficking and survival predict effective strategies to control graft-versus-host disease following allogeneic transplantation.

    Vu H. Nguyen;Robert Zeiser;Daniel L. daSilva;Daisy S. Chang

Frequent Co-Authors

Jürgen Finke
Jürgen Finke University of Freiburg
Robert S. Negrin
Robert S. Negrin Stanford University
Bruce R. Blazar
Bruce R. Blazar University of Minnesota
Dietmar Pfeifer
Dietmar Pfeifer University of Freiburg
Marie Follo
Marie Follo University of Freiburg
Melanie Boerries
Melanie Boerries University of Freiburg
Marco Idzko
Marco Idzko Medical University of Vienna
Michael Lübbert
Michael Lübbert University of Freiburg
Gérard Socié
Gérard Socié Université Paris Cité
Geoffrey R. Hill
Geoffrey R. Hill Fred Hutchinson Cancer Research Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in advancing their careers in immunology, exploring related online degrees and career pathways can open many doors. Many professionals consider pursuing a Doctorate in Nursing, and understanding the doctorate in nursing salary can help gauge the long-term benefits of such a commitment. This degree offers specialized knowledge that complements immunological expertise, especially in clinical and research settings.

Nurses aiming to transition within advanced practice roles might explore an fnp to acnp bridge program online. This pathway allows Family Nurse Practitioners to shift focus toward acute care, which often intersects with immunology through managing complex immune-related conditions.

Additionally, accelerated programs can fast-track credentials for healthcare professionals. The accelerated nurse practitioner program options are ideal for ambitious students seeking efficient entry into advanced practice with a focus that may align with immunology specialties.

For those beginning their journey, online rn programs for non nurses provide accessible routes into nursing careers. These programs lay a strong foundation in clinical knowledge, which is crucial for anyone interested in immunology-driven healthcare roles.

Best Scientists Citing Robert Zeiser

Trending Scientists